We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£490.00
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics for US Zip Codes
Price data last checked 28 day(s) ago - will refresh soon
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£490 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 63 days • 63 data points (No recent data available)
Price Distribution
Price distribution over 63 days • 1 price levels
Price Analysis
Most common price: £490 (63 days, 100.0%)
Price range: £490 - £490
Price levels: 1 different prices over 63 days
Product Specifications
- Format
- paperback
- ASIN
- B0BSJC3LY7
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 09 January 2023
- Listed Since
- 27 January 2023
Similar Products You Might Like
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in Japan
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in India
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Africa & the Middle East
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Latin America
The 2013-2018 Outlook for Pancreatic Cancer Drugs in North America & the Caribbean
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Europe
The 2011-2016 Outlook for Pancreatic Cancer Drugs in The Middle East
The 2021-2026 World Outlook for Pancreatic Cancer Drugs
The 2011-2016 Outlook for Pancreatic Cancer Drugs in Africa
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana
Multidisciplinary Management of Acute and Chronic Pancreatitis
IntechOpen
The 2023-2028 Outlook for Peptides and Heparin for Diabetes for US Zip Codes
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
The 2023-2028 Outlook for Pen Insulin Syringes for US Zip Codes
Chronic Pancreatitis
IntechOpen
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Europe
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
Chronic Pancreatitis: From Basic Research to Clinical Treatment
Springer
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Greater China
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India
Pancreatic Islet Cell Regeneration and Growth: Proceedings of a Diabetes Institute Conference Held in Norfolk, Virginia, June 22-23, 1991: v. 321 (Advances in Experimental Medicine and Biology)
Springer